Celularity Inc. (CELU) vs Microbot Medical Inc. (MBOT)
A side-by-side comparison of Celularity Inc. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELU
Celularity Inc.
$1.72HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
MBOT
Microbot Medical Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — CELU vs MBOT
growth of $100 · dividends reinvested · last 7yCELU -98.3% (-43.9%/yr)MBOT -82.3% (-21.9%/yr)MBOT compounded faster over this window
Log scale — wide-divergence pair
CELU MBOT
CELU vs MBOT: by the numbers
- •MBOT is the larger company ($50M vs $50M market cap).
- •Both run net losses; CELU's is the smaller (-375.77% vs -4722.25% net margin).
Metrics side by side
Valuation
| Metric | CELU | MBOT |
|---|---|---|
| P/S ratio | 2.63 | 145.54 |
| P/B ratio | N/A | 0.73 |
Profitability
| Metric | CELU | MBOT |
|---|---|---|
| Gross margin | 79.62% | 0.00% |
| Operating margin | -230.92% | 0.00% |
| Net margin | -375.77% | -4722.25% |
| ROE | N/A | -23.70% |
| ROIC | -192.99% | -26.51% |
Growth (annualized)
| Metric | CELU | MBOT |
|---|---|---|
| Revenue CAGR (5Y) | 8.31% | N/A |
| Total return CAGR (5Y) | -52.57% | -31.63% |
Frequently asked
- How have CELU and MBOT total returns compared?
- Over the past 5 years, CELU delivered -52.57% and MBOT delivered -31.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.